Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TNFRSF21 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | SERPINB5 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | CCR6 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | TMEM30B | CCLE | pan-cancer | AAC | 0.25 | 7e-06 |
mRNA | RHOD | CCLE | pan-cancer | AAC | 0.27 | 7e-06 |
mRNA | MAL | CCLE | pan-cancer | AAC | 0.22 | 7e-06 |
mRNA | COL17A1 | CCLE | pan-cancer | AAC | 0.24 | 7e-06 |
mRNA | FGFBP1 | CCLE | pan-cancer | AAC | 0.25 | 8e-06 |
mRNA | KLK5 | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
mRNA | TMPRSS11E | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |